Insider · CIK 0001219927

TABUTEAU HERRIOT

Reports to the SEC for 1 company · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001219927

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-06	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	+4,660 sh	$4.95	+$23.1K	11,889
2026-08-06	AXSMAxsome Therapeutics, Inc.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−4,660 sh	$213.95	−$997K	7,229
2026-08-06	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	−4,660 sh	—	—	0
2026-08-05	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	+45K sh	$4.95	+$223K	52,233
2026-08-05	AXSMAxsome Therapeutics, Inc.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−45K sh	$212.01	−$9.54M	7,229
2026-08-05	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	−45K sh	—	—	4,660
2026-07-01	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	+49.7K sh	$4.95	+$246K	56,895
2026-07-01	AXSMAxsome Therapeutics, Inc.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−49.7K sh	$240.25	−$11.9M	7,229
2026-07-01	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	−49.7K sh	—	—	49,664
2026-06-09	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	+49.7K sh	$4.95	+$246K	56,899
2026-06-09	AXSMAxsome Therapeutics, Inc.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−49.7K sh	$241.01	−$12M	7,229
2026-06-09	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	−49.7K sh	—	—	99,330
2026-04-21	AXSMAxsome Therapeutics, Inc. · Performance Stock UnitsA Award	Director, Chief Executive Officer, 10% Owner	AAward	+24.1K sh	—	—	24,081
2026-02-26	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	Director, Chief Executive Officer, 10% Owner	AAward	+54.6K sh	—	—	54,623
2026-02-02	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	+32.4K sh	$8.02	+$260K	39,639
2026-02-02	AXSMAxsome Therapeutics, Inc.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−32.4K sh	$185.60	−$6.02M	7,229
2026-02-02	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	−32.4K sh	—	—	0
2026-01-07	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	+31.3K sh	$8.02	+$251K	38,490
2026-01-07	AXSMAxsome Therapeutics, Inc.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−31.3K sh	$170.38	−$5.33M	7,229
2026-01-07	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	−31.3K sh	—	—	32,410
2026-01-06	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	+29.5K sh	$8.02	+$236K	36,679
2026-01-06	AXSMAxsome Therapeutics, Inc.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−29.5K sh	$172.33	−$5.08M	7,229
2026-01-06	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	−29.5K sh	—	—	63,671
2026-01-05	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	+78.7K sh	$8.02	+$631K	85,932
2026-01-05	AXSMAxsome Therapeutics, Inc.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−78.7K sh	$171.28	−$13.5M	7,229
2026-01-05	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	−78.7K sh	—	—	93,121
2025-12-04	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	+10.6K sh	$8.02	+$84.7K	17,787
2025-12-04	AXSMAxsome Therapeutics, Inc.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−10.6K sh	$148.18	−$1.56M	7,229
2025-12-04	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	−10.6K sh	—	—	171,824
2025-12-03	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	+20.2K sh	$8.02	+$162K	27,392
2025-12-03	AXSMAxsome Therapeutics, Inc.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−20.2K sh	$146.94	−$2.96M	7,229
2025-12-03	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	−20.2K sh	—	—	182,382
2025-12-02	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	+49.3K sh	$8.02	+$395K	56,481
2025-12-02	AXSMAxsome Therapeutics, Inc.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−49.3K sh	$144.59	−$7.12M	7,229
2025-12-02	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	−49.3K sh	—	—	202,545
2025-11-05	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	+21.8K sh	$8.02	+$175K	29,004
2025-11-05	AXSMAxsome Therapeutics, Inc.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−21.8K sh	$134.49	−$2.93M	7,229
2025-11-05	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	−21.8K sh	—	—	251,797
2025-11-04	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	+50.5K sh	$8.02	+$405K	57,688
2025-11-04	AXSMAxsome Therapeutics, Inc.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−50.5K sh	$133.79	−$6.75M	7,229
2025-11-04	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	−50.5K sh	—	—	273,572
2025-11-03	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	+91.7K sh	$8.02	+$735K	98,934
2025-11-03	AXSMAxsome Therapeutics, Inc.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−91.7K sh	$132.34	−$12.1M	7,229
2025-11-03	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	−91.7K sh	—	—	324,031
2025-10-08	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	+12.8K sh	$8.02	+$102K	20,003
2025-10-08	AXSMAxsome Therapeutics, Inc.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−12.8K sh	$118.84	−$1.52M	7,229
2025-10-08	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	−12.8K sh	—	—	415,736
2025-10-07	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	+13.4K sh	$8.02	+$107K	20,619
2025-10-07	AXSMAxsome Therapeutics, Inc.S Sale	Director, Chief Executive Officer, 10% Owner	SSale	−13.4K sh	$118.77	−$1.59M	7,229
2025-10-07	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer, 10% Owner	MExercise/Conversion	−13.4K sh	—	—	428,510

Recent filings

Accepted (ET)
Aug 74
TABUTEAU HERRIOT0001193125-26-340688
SEC(opens sec.gov)
Jul 14
TABUTEAU HERRIOT0001193125-26-292985
SEC(opens sec.gov)
Jun 94
TABUTEAU HERRIOT0001193125-26-264038
SEC(opens sec.gov)
Apr 234
TABUTEAU HERRIOT0001193125-26-174417
SEC(opens sec.gov)
Feb 274
TABUTEAU HERRIOT0001193125-26-083609
SEC(opens sec.gov)
Feb 24
TABUTEAU HERRIOT0001193125-26-033973
SEC(opens sec.gov)
Jan 74
TABUTEAU HERRIOT0001193125-26-006695
SEC(opens sec.gov)

Companies

Axsome Therapeutics, Inc.Director, Chief Executive Officer, 10% OwnerAXSM

Address

C/O AXSOME THERAPEUTICS, INC. ONE WORLD TRADE CENTER, 29TH FLOOR

NEW YORK, NY, 10007